IJSSELSTEIN, Netherlands--(BUSINESS WIRE)--In line with its strategic objective to build a global network of service centers in close proximity to leading genomics researchers, Ocimum Biosolutions B.V. today announced the launch of genomic services on Affymetrix platform from Europe. Initially Ocimum will service Gene Expression studies on the Affymetrix platform from its facility at IJsselstein, The Netherlands. Within a couple of months, it will launch the entire bouquet of services from its IJsselstein facility.
